White paper
Outcomes based measures for Pharma new commercial models
September 29, 2010Sales and Marketing Kinapse, White paper
It is now widely recognised that Pharma new commercial models will rely on the principles of account management, working collaboratively …
New Commercial Realities Paper Pt 3 – The changing landscape for pharmaceutical commercial operations – roles and organisational scale
September 29, 2010Sales and Marketing Kinapse, White paper
Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the industry’s traditional commercial models based on …
Realising outsourcing’s potential
September 20, 2010Sales and Marketing Kinapse, White paper
IntroductionAs the budgets of pharma companies face continued downward pressure, the objective of outsourcing is not only to find effective …
Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 2
August 26, 2010Research and Development Kinapse, White paper, life sciences, pharma
With fierce competition in the market for late stage life sciences assets, pharmaceutical companies seeking partnering strategies to bolster pipelines …
Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 1
August 11, 2010Research and Development Kinapse, life sciences, pharma
Valuations are essential components of effective transactions in the life sciences industry
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
